Pinta (disease): Difference between revisions

Jump to navigation Jump to search
No edit summary
 
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
'''For patient information click [[{{PAGENAME}} (patient information)|here]]'''
{{Pinta}}
{{Pinta}}
{{CMG}}
{{CMG}}


==[[Pinta overview|Overview]]==


'''Pinta''' is a human [[skin disease]] endemic to Mexico, Central America, and South America. It is caused by infection with a [[spirochete]], ''Treponema carateum'', which is [[Comparative anatomy|morphologically]] and [[serology|serologically]] indistinguishable from the organism that causes [[syphilis]].
==[[Pinta historical perspective|Historical Perspective]]==


Pinta initially presents as a raised [[papule]], followed by a generalized eruption of flat, reddened areas, and is followed by the development of bluish coloration and a subsequent loss of pigmentation. Unlike syphilis, it is transmitted by nonsexual skin contact, often between children living in conditions of poor hygiene.
==[[Pinta pathophysiology|Pathophysiology]]==


The disease can be treated with [[penicillin]], [[tetracycline]], or [[chloramphenicol]], and can be prevented through contact tracing by [[public health]] officials.
==[[Pinta causes|Causes]]==
 
==[[Pinta differential diagnosis|Differentiating Pinta from other Diseases]]==
 
==[[Pinta epidemiology and demographics|Epidemiology and Demographics]]==
 
==[[Pinta risk factors|Risk Factors]]==
 
==[[Pinta natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
 
==Diagnosis==
[[Pinta history and symptoms|History and Symptoms]] | [[Pinta physical examination|Physical Examination]] | [[Pinta laboratory findings|Laboratory Findings]] | [[Pinta other diagnostic studies|Other Diagnostic Studies]]
 
==Treatment==
[[Pinta medical therapy|Medical Therapy]] | [[Pinta primary prevention|Prevention]] | [[Pinta cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Pinta future or investigational therapies|Future or Investigational Therapies]]
 
==Case Studies==
[[Pinta case study one|Case #1]]


==Related Chapters==
==Related Chapters==
Line 21: Line 40:


[[Category:Disease]]
[[Category:Disease]]
[[Category:Bacterial diseases]]
[[Category:Bacterial diseases]]
[[Category:Dermatology]]
[[Category:Dermatology]]

Revision as of 13:21, 11 December 2012

For patient information click here

Pinta Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Pinta from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pinta (disease) On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pinta (disease)

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA onPinta (disease)

CDC on Pinta (disease)

(disease) in the news

on Pinta (disease)

Directions to Hospitals Treating Pinta

Risk calculators and risk factors for Pinta (disease)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Pinta from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Related Chapters

Template:Spirochetal diseases nl:Pinta (infectieziekte) Template:SIB Template:WH Template:WS